{"mainPropery":{"diseaseId":9298,"diseaseName":"Pyridoxine-dependent epilepsy","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9298/pyridoxine-dependent-epilepsy","synonyms":["Pyridoxine dependency","Pyridoxine dependency with seizures","Vitamin B6-dependent seizures","Antiquitin deficiency"],"synonyms-with-source":[{"name":"Pyridoxine dependency"},{"name":"Pyridoxine dependency with seizures"},{"name":"Vitamin B6-dependent seizures"},{"name":"Antiquitin deficiency","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"OMIM","identifierId":"266100"},{"identifierType":"ORPHANET","identifierId":"3006"},{"identifierType":"UMLS","identifierId":"C1849508"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":413,"resourceName":"Epilepsy Foundation","abbreviation":"","address1":"8301 Professional Place East","address2":"Suite 230","address3":"","address4":"","address5":"","city":"Landover","state":"MD","zip":"20785","country":"United States","phone":"+1-301-459-3700 ","tty":"","tollFree":"800-332-1000 (24/7 Helpline)","fax":"+1-301-577-2684","email":"contactus@efa.org","url":"https://www.epilepsy.com/","freeText":"en Espa√±ol 1-866-748-8008"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/266100' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=266100' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Pyridoxine-dependent epilepsy. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=pyridoxinedependentepilepsy' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Pyridoxine-dependent epilepsy. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1849508' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://rarediseases.org/rare-diseases/pyridoxine-dependent-epilepsy/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/985667-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=3006' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=pds' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:266100' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":1990,"questionText":"What is pyridoxine-dependent epilepsy?","answerText":"<strong>Pyridoxine-dependent epilepsy</strong> is a condition that involves seizures beginning in infancy or, in some cases, before birth. Those affected typically experience prolonged seizures lasting several minutes (status epilepticus). These seizures involve muscle rigidity, convulsions, and loss of consciousness (tonic-clonic seizures).&nbsp;Anticonvulsant drugs, which are usually given to control seizures, are ineffective in people with pyridoxine-dependent epilepsy. Instead, people with this type of seizure are medically treated with large daily doses of <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682587.html\" target=\"_blank\">pyridoxine</a> (a type of vitamin B6 found in food).&nbsp;Mutations in the <a class=\"link-dapple\" title=\"A L D H 7 A 1\" href=\"http://ghr.nlm.nih.gov/gene=aldh7a1\" target=\"_blank\"><span><em>ALDH7A1</em></span></a> gene cause pyridoxine-dependent epilepsy. This gene&nbsp;is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> fashion.[1223]","dateModified":"2013-07-23T15:49:00"},"basicQuestions":[{"questionId":1991,"questionText":"What symptoms are associated with pyridoxine-dependent epilepsy?","answerText":"Those affected by pyridoxine-dependent epilepsy typically experience prolonged seizures lasting several minutes (status epilepticus). These seizures involve muscle rigidity, convulsions, and loss of consciousness (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000695.htm\" target=_blank>tonic-clonic seizures</a>). Additional features of pyridoxine-dependent epilepsy include low body temperature (<a href=\"http://www.nlm.nih.gov/medlineplus/hypothermia.html\" target=_blank>hypothermia</a>), poor muscle tone (<a href=\"http://www.nlm.nih.gov/medlineplus/dystonia.html\" target=_blank>dystonia</a>) soon after birth, and irritability before a seizure episode. In rare instances, children with this condition do not have seizures until they are 1 to 3 years old.&nbsp;&nbsp;If left untreated, people with this condition can develop severe brain dysfunction (<a href=\"http://www.ninds.nih.gov/disorders/encephalopathy/encephalopathy.htm\" target=_blank>encephalopathy</a>). Even though seizures can be controlled with <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682587.html\" target=_blank>pyridoxine</a>, neurological problems such as developmental delay and learning disorders may still occur.[1223]","dateModified":"2013-07-23T15:49:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1223,"authors":"","articleTitle":"Pyridoxine-dependent epilepsy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2013","url":"http://ghr.nlm.nih.gov/condition=pyridoxinedependentepilepsy","dateAccessed":"2013-07-23T00:00:00"}]},{"questionId":1992,"questionText":"What causes pyridoxine-dependent epilepsy?","answerText":"<p>Mutations in the <a class=link-dapple title=\"A L D H 7 A 1\" href=\"http://ghr.nlm.nih.gov/gene=aldh7a1\" target=_blank><span>ALDH7A1</span></a> gene cause pyridoxine-dependent epilepsy.&nbsp;This condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.[1223]<br><br>The ALDH7A1 gene provides instructions for making an enzyme called &#945;-aminoadipic semialdehyde (&#945;-AASA) dehydrogenase, also known as antiquitin. This enzyme is involved in the breakdown of the protein building block (amino acid) lysine in the brain.[1223]</p>\r\n<p>When antiquitin is deficient, a molecule that interferes with vitamin B6 function builds up in various tissues. Pyridoxine plays a role in many processes in the body, such as the breakdown of amino acids and the productions of chemicals that transmit signals in the brain (neurotransmitters). It is unclear how a lack of pyridoxine causes the seizures that are characteristic of this condition.[1223]</p>\r\n<p>Some individuals with pyridoxine-dependent epilepsy do not have identified mutations in the ALDH7A1 gene. In these cases, the cause of the condition is unknown.[1223]</p>","dateModified":"2013-07-23T15:39:00","resourceClassificationName":"Cause","references":[{"referenceId":1223,"authors":"","articleTitle":"Pyridoxine-dependent epilepsy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2013","url":"http://ghr.nlm.nih.gov/condition=pyridoxinedependentepilepsy","dateAccessed":"2013-07-23T00:00:00"}]},{"questionId":1993,"questionText":"How might pyridoxine-dependent epilepsy be treated?","answerText":"Anticonvulsant drugs, which are usually given to control seizures, are ineffective in people with pyridoxine-dependent epilepsy. Instead, people with this type of seizure are medically treated with large daily doses of pyridoxine (a type of vitamin B6 found in food).[1223][1224]&nbsp;Recent studies have focused on using a lysine-restricted diet in addition to pyridoxine. Preliminary results suggest that this treatment has the potential to help control seizures and improve developmental outcomes in children with pyridoxine-dependent epilepsy.[6123] ","dateModified":"2013-07-23T15:46:00","resourceClassificationName":"Treatment","references":[{"referenceId":1223,"authors":"","articleTitle":"Pyridoxine-dependent epilepsy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2013","url":"http://ghr.nlm.nih.gov/condition=pyridoxinedependentepilepsy","dateAccessed":"2013-07-23T00:00:00"},{"referenceId":1224,"authors":"Gospe SM","articleTitle":"Pyridoxine-Dependent Seizures","bookWebsiteJournalTitle":"GeneReviews","date":"2012","url":"http://www.ncbi.nlm.nih.gov/books/NBK1486/","dateAccessed":"2013-07-23T00:00:00"},{"referenceId":6123,"authors":"","articleTitle":"","bookWebsiteJournalTitle":"van Karnebeek CD et al. Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and future trials. Mol Genet Metab. 2012 Nov;107(3):335-44. ","date":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":23819,"abbreviatedInquiry":"My daughter was diagnosed with pyridoxine-dependent epilepsy at birth. Her symptoms were controlled until a few years ago when she began to have muscle stiffness in the hands and legs, partial seizures, and loss of her voice. Her seizures now occur almost daily and are quite violent. Her doctors believe that her&nbsp;seizure activity&nbsp;may now be&nbsp;the result of&nbsp;psychogenic nonepileptic seizures (PNES). Is this a common occurrence in adults with pyridoxine-dependent epilepsy?","caseQuestions":[{"questionId":1990,"questionText":"What is pyridoxine-dependent epilepsy?","answerText":"<strong>Pyridoxine-dependent epilepsy</strong> is a condition that involves seizures beginning in infancy or, in some cases, before birth. Those affected typically experience prolonged seizures lasting several minutes (status epilepticus). These seizures involve muscle rigidity, convulsions, and loss of consciousness (tonic-clonic seizures).&nbsp;Anticonvulsant drugs, which are usually given to control seizures, are ineffective in people with pyridoxine-dependent epilepsy. Instead, people with this type of seizure are medically treated with large daily doses of <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682587.html\" target=\"_blank\">pyridoxine</a> (a type of vitamin B6 found in food).&nbsp;Mutations in the <a class=\"link-dapple\" title=\"A L D H 7 A 1\" href=\"http://ghr.nlm.nih.gov/gene=aldh7a1\" target=\"_blank\"><span><em>ALDH7A1</em></span></a> gene cause pyridoxine-dependent epilepsy. This gene&nbsp;is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> fashion.[1223]","dateModified":"2013-07-23T15:49:00","references":[{"referenceId":1223,"authors":"","articleTitle":"Pyridoxine-dependent epilepsy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2013","url":"http://ghr.nlm.nih.gov/condition=pyridoxinedependentepilepsy","dateAccessed":"2013-07-23T00:00:00"}]},{"questionId":10713,"questionText":"What are dissociative seizures?","answerText":"<strong>Dissociative or psychogenic nonepileptic seizures </strong>(PNES)&nbsp;are involuntary episodes of movement, sensation, or behaviors (vocalizations, crying, and other expressions of emotion) that do not result from abnormal brain discharges. The seizures can look like any kind of epileptic seizure. &nbsp;They are somatic manifestations (<span>physical symptoms) </span>of psychologic distress. Psychiatric conditions associated with PNES include depression, anxiety, <a href=\"http://www.webmd.com/mental-health/somatoform-disorders-symptoms-types-treatment\" target=\"_blank\">somatoform disorder</a>, <a href=\"http://www.nimh.nih.gov/health/topics/post-traumatic-stress-disorder-ptsd/index.shtml\" target=\"_blank\">posttraumatic stress disorder</a>, <a href=\"https://www.nami.org/Learn-More/Mental-Health-Conditions/Dissociative-Disorders\" target=\"_blank\">dissociative disorder</a>, and <a href=\"https://www.nlm.nih.gov/medlineplus/personalitydisorders.html\" target=\"_blank\">personality disorders</a>. Treatment depends on the cause of the psychologic distress, and may involve  <a href=\"http://www.mayoclinic.org/tests-procedures/cognitive-behavioral-therapy/home/ovc-20186868\" target=\"_blank\">cognitive behavioral therapy</a> or <a href=\"http://www.mayoclinic.org/tests-procedures/psychotherapy/home/ovc-20197188\" target=\"_blank\">psychotherapy</a>, as well as antidepressive medication.[11608][11609]","dateModified":"2016-05-30T20:50:00","references":[{"referenceId":11608,"authors":"Alsaadi TM & Marquez AV","articleTitle":"Psychogenic Nonepileptic Seizures","bookWebsiteJournalTitle":"American Family Physicians","date":"2005","volume":"72(5)","pages":"849-856","url":"http://www.aafp.org/afp/2005/0901/p849.html","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11609,"authors":"Ettinger AB","articleTitle":"Psychogenic nonepileptic seizures","bookWebsiteJournalTitle":"UpToDate","date":"April, 2016","volume":"","pages":"","url":"http://www.uptodate.com/contents/psychogenic-nonepileptic-seizures","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1991,"questionText":"What symptoms are associated with pyridoxine-dependent epilepsy?","answerText":"Those affected by pyridoxine-dependent epilepsy typically experience prolonged seizures lasting several minutes (status epilepticus). These seizures involve muscle rigidity, convulsions, and loss of consciousness (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000695.htm\" target=_blank>tonic-clonic seizures</a>). Additional features of pyridoxine-dependent epilepsy include low body temperature (<a href=\"http://www.nlm.nih.gov/medlineplus/hypothermia.html\" target=_blank>hypothermia</a>), poor muscle tone (<a href=\"http://www.nlm.nih.gov/medlineplus/dystonia.html\" target=_blank>dystonia</a>) soon after birth, and irritability before a seizure episode. In rare instances, children with this condition do not have seizures until they are 1 to 3 years old.&nbsp;&nbsp;If left untreated, people with this condition can develop severe brain dysfunction (<a href=\"http://www.ninds.nih.gov/disorders/encephalopathy/encephalopathy.htm\" target=_blank>encephalopathy</a>). Even though seizures can be controlled with <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682587.html\" target=_blank>pyridoxine</a>, neurological problems such as developmental delay and learning disorders may still occur.[1223]","dateModified":"2013-07-23T15:49:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1223,"authors":"","articleTitle":"Pyridoxine-dependent epilepsy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2013","url":"http://ghr.nlm.nih.gov/condition=pyridoxinedependentepilepsy","dateAccessed":"2013-07-23T00:00:00"}]},{"questionId":1992,"questionText":"What causes pyridoxine-dependent epilepsy?","answerText":"<p>Mutations in the <a class=link-dapple title=\"A L D H 7 A 1\" href=\"http://ghr.nlm.nih.gov/gene=aldh7a1\" target=_blank><span>ALDH7A1</span></a> gene cause pyridoxine-dependent epilepsy.&nbsp;This condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.[1223]<br><br>The ALDH7A1 gene provides instructions for making an enzyme called &#945;-aminoadipic semialdehyde (&#945;-AASA) dehydrogenase, also known as antiquitin. This enzyme is involved in the breakdown of the protein building block (amino acid) lysine in the brain.[1223]</p>\r\n<p>When antiquitin is deficient, a molecule that interferes with vitamin B6 function builds up in various tissues. Pyridoxine plays a role in many processes in the body, such as the breakdown of amino acids and the productions of chemicals that transmit signals in the brain (neurotransmitters). It is unclear how a lack of pyridoxine causes the seizures that are characteristic of this condition.[1223]</p>\r\n<p>Some individuals with pyridoxine-dependent epilepsy do not have identified mutations in the ALDH7A1 gene. In these cases, the cause of the condition is unknown.[1223]</p>","dateModified":"2013-07-23T15:39:00","resourceClassificationName":"Cause","references":[{"referenceId":1223,"authors":"","articleTitle":"Pyridoxine-dependent epilepsy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2013","url":"http://ghr.nlm.nih.gov/condition=pyridoxinedependentepilepsy","dateAccessed":"2013-07-23T00:00:00"}]},{"questionId":1993,"questionText":"How might pyridoxine-dependent epilepsy be treated?","answerText":"Anticonvulsant drugs, which are usually given to control seizures, are ineffective in people with pyridoxine-dependent epilepsy. Instead, people with this type of seizure are medically treated with large daily doses of pyridoxine (a type of vitamin B6 found in food).[1223][1224]&nbsp;Recent studies have focused on using a lysine-restricted diet in addition to pyridoxine. Preliminary results suggest that this treatment has the potential to help control seizures and improve developmental outcomes in children with pyridoxine-dependent epilepsy.[6123] ","dateModified":"2013-07-23T15:46:00","resourceClassificationName":"Treatment","references":[{"referenceId":1223,"authors":"","articleTitle":"Pyridoxine-dependent epilepsy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2013","url":"http://ghr.nlm.nih.gov/condition=pyridoxinedependentepilepsy","dateAccessed":"2013-07-23T00:00:00"},{"referenceId":1224,"authors":"Gospe SM","articleTitle":"Pyridoxine-Dependent Seizures","bookWebsiteJournalTitle":"GeneReviews","date":"2012","url":"http://www.ncbi.nlm.nih.gov/books/NBK1486/","dateAccessed":"2013-07-23T00:00:00"},{"referenceId":6123,"authors":"","articleTitle":"","bookWebsiteJournalTitle":"van Karnebeek CD et al. Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and future trials. Mol Genet Metab. 2012 Nov;107(3):335-44. ","date":""}]},{"questionId":1995,"questionText":"Is it common for adults with pyridoxine-dependent epilepsy to develop psychogenic nonepileptic seizures?&nbsp;","answerText":"After an extensive search of the resources available to us, we have not been able to identify any reports which discuss&nbsp;individuals with pyridoxine-dependent epilepsy who have developed psychogenic nonepileptic seizures in adulthood.&nbsp;<br />\r\n<br />\r\nYou may wish to contact the following organizations which deal specifically with epilepsy to see if they are aware of any such cases. These groups may also be able to recommend a specialist who can assist your daughter in control of her symptoms.<br />\r\n<br />\r\nEpilepsy Foundation<br />\r\n8301 Professional Place <br />\r\nEast Landover, MD 20785-2238 <br />\r\nToll-free:&nbsp;800-EFA-1000 (800-332-1000)<br />\r\nPhone: 301-459-3700 <br />\r\nFax: 301-577-4941 <br />\r\nEmail: <a href=\"mailto:webmaster@efa.org\">webmaster@efa.org</a> &nbsp;<br />\r\n<span class=\"ext-reflink\">Web: <a class=\"ext-reflink\" onclick=\"focuswin('pmc_ext')\" href=\"http://www.efa.org/\" target=\"pmc_ext\">www.efa.org</a></span>\r\n<p ><br />\r\nAmerican Epilepsy Society<br />\r\n342 North Main Street <br />\r\nWest Hartford CT 06117-2507 <br />\r\nPhone: 860-586-7505 <br />\r\nFax: 860-586-7550 <br />\r\nEmail: <a href=\"mailto:info@aesnet.org\">info@aesnet.org</a> &nbsp;<br />\r\n<span class=\"ext-reflink\">Web: <a class=\"ext-reflink\" onclick=\"focuswin('pmc_ext')\" href=\"http://www.aesnet.org/\" target=\"pmc_ext\">www.aesnet.org</a></span><br />\r\n<br />\r\n&nbsp;</p>","dateModified":"2016-08-30T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13037,"phenoTypeName":"Abnormality of metabolism/homeostasis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11464,"phenoTypeName":"Abnormality of movement","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11431,"phenoTypeName":"EEG abnormality","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13842,"phenoTypeName":"Neurological speech impairment","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13751,"phenoTypeName":"Status epilepticus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13743,"phenoTypeName":"Cerebral cortical atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10498,"phenoTypeName":"Strabismus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13742,"phenoTypeName":"Ventriculomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":13458,"phenoTypeName":"Bilateral tonic-clonic seizure","percentRanges":"-"},{"phenoTypeId":14142,"phenoTypeName":"Delayed speech and language development","percentRanges":"-"},{"phenoTypeId":5352,"phenoTypeName":"Fetal distress","percentRanges":"-"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","percentRanges":"-"},{"phenoTypeId":13747,"phenoTypeName":"Generalized myoclonic seizure","percentRanges":"-"},{"phenoTypeId":13809,"phenoTypeName":"Neonatal respiratory distress","percentRanges":"-"},{"phenoTypeId":4735,"phenoTypeName":"Prenatal movement abnormality","percentRanges":"-"},{"phenoTypeId":13728,"phenoTypeName":"Respiratory distress","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Pyridoxine-dependent_epilepsy"}